Document is current
Any future updates will be listed below
-
Authors
Vincer, Michael J.
Reilly, Maureen C.
Vohra, Sunita
Rac, Valeria E.
Bhaloo, Zafira
Dunn, Michael
Ferrelli, Karla
Kiss, Alex
Wimmer, John
Zayack, Denise
Soll, Roger
,
-
Funding
Funding for this research was provided by:
Stollery Children’s Hospital Foundation (G599000746)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 8 April 2025
First Online: 8 August 2026
Declarations
Ethics approval and consent to participate: The study team had the approval from Steering Committee site at Sunnybrook Health Sciences Centre, Toronto, (Research Ethics Board #15–0243-C; 7 October 2015) where the data was stored. Each participating institution submitted a copy of their institution’s Institutional Review Board approval and the need for a consent form or waiver of consent and subsequent annual renewals to the VON HeLP Trial Coordinating Center. This approval process included the enrollment of their child in their local follow-up program (where such a program existed) to evaluate the child between 18–24 months CGA. This work has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
